Idebenone for the Preventive Treatment of Migraine
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Idebenone improves energy metabolism similarly to Coenzyme Q10, which is effective in
migraine prophylaxis. The investigators compare idebenone (90 mg/day, 270 mg/day) and placebo
in 180 migraine patients in a double-blind, randomized, placebo-controlled, multicenter trial
to study whether Idebenone is superior to placebo in the prevention of episodic migraine with
or without aura.
Phase:
Phase 3
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University